GeneDx Holdings Corp. Operating Lease, Expense
GeneDx Holdings Corp. (WGS) reported Operating Lease, Expense of $1.54 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2023-08-08
- GeneDx Holdings Corp. operating lease, expense for the quarter ending 2023-06-30 was $1.54M, a 2.78% decline year-over-year.
- GeneDx Holdings Corp. operating lease, expense for the quarter ending 2023-03-31 was $1.74M, a 25.72% increase year-over-year.
- GeneDx Holdings Corp. operating lease, expense for the quarter ending 2022-12-31 was $1.28M.
- GeneDx Holdings Corp. operating lease, expense for the quarter ending 2022-09-30 was $1.80M.
- GeneDx Holdings Corp. operating lease, expense for fiscal 2022 was $6.04M.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2023-06-30 | $1.54M 10-Q · filed 2023-08-08 | $3.27M 10-Q · filed 2023-08-08 | $4.55M derived: sum of 3 quarters · filed 2023-08-08 | $6.36M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $1.74M 10-Q · filed 2023-05-09 | $3.02M derived: sum of 2 quarters · filed 2023-05-09 | $4.82M derived: sum of 3 quarters · filed 2023-05-09 | $6.40M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.08M derived: sum of 2 quarters · filed 2023-03-16 | $4.66M derived: sum of 3 quarters · filed 2023-08-08 | $6.04M 10-K · filed 2023-03-16 |
| 2022-09-30 | $1.80M 10-Q · filed 2022-11-14 | $3.38M derived: sum of 2 quarters · filed 2023-08-08 | $4.76M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.58M 10-Q · filed 2023-08-08 | $2.96M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $1.38M 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |